Edition: Global  
One News Page
“Probably the fastest-access news portal in the world”
> >

Some Teenagers Recreated Martin Shkreli's Crazy-Expensive Drug For $20

Huffington Post Thursday, 1 December 2016
When Martin Shkreli, the former CEO of Turing Pharmaceuticals, hiked up the price of a life-saving medication, one group of high school students saw an opportunity to do good.

Eight teenagers from Sydney Grammar School in Australia have collaborated with scientists from the University of Sydney to reproduce the active...
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 
Source: Newsy Studio - < > Embed

News video: Teenagers Recreate $750 Martin Shkreli Drug for $2 a Dose

Teenagers Recreate $750 Martin Shkreli Drug for $2 a Dose 01:16

A group of Australian students say they recreated the active ingredient in life-saving drug Daraprim for a fraction of its U.S. price.

You Might Like


Recent related news

The 12 best reasons why jurors were dismissed from Martin Shkreli's trial

The 12 best reasons why jurors were dismissed from Martin Shkreli's trial
Insult was added to injury for disgraced former biopharma and hedge fund boss Martin Shkreli yesterday, as court transcripts emerged which revealed the American...
City A.M. - BusinessAlso reported by •MashableBusiness Insider

Martin Shkreli: SEC Targeted Me for Being 'Flamboyant'

Martin Shkreli, the former pharmaceutical CEO recently found guilty of securities fraud, said Tuesday that he was singled out by federal officials for being...
Newsmax - USAlso reported by •Gothamist

Other recent news in Politics

Trump, first lady will not attend KENNEDY CENTER Honors: White HouseBoston Braces For Spirited ‘FREE SPEECH’ Rally
DUKE UNIVERSITY Is Removing The Robert E. Lee Statue From Its Chapel

Twitter

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+